Study to reveal hidden costs of weight gain in IBD patients on biologics
NCT ID NCT07495800
First seen Apr 07, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study will track weight and body mass index (BMI) changes in 50 people with inflammatory bowel disease (IBD) who are being treated with biologic drugs. Researchers want to see if weight gain leads to higher drug doses and increased treatment costs. The goal is to understand the financial impact of weight changes during biologic therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES WEIGHT CHANGES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.